| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $46K | — | — |
| SG&A Expense | $1.8M | — | — |
| Operating Income | -$1.8M | — | — |
| Net Income | -$1.8M | — | — |
| EPS (Basic) | -$0.08 | — | — |
| EPS (Diluted) | -$0.08 | — | — |
| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $492K | — | — |
| Current Assets | $514K | — | — |
| Total Assets | $6.7M | — | — |
| Current Liabilities | $20.0M | — | — |
| Total Liabilities | $20.2M | — | — |
| Stockholders' Equity | -$13.5M | — | — |
| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | — |
| Capital Expenditures | $1K | — | — |
| Investing Cash Flow | $543K | — | — |
| Financing Cash Flow | $2.3M | — | — |
| Free Cash Flow | -$2.4M | — | — |